We previously reported that several human pancreatic cancer cell lines up-regulate the expression of DUOX2 and DUOXA2 in response to treatment with the pro-inflammatory cytokines IFN-γ and LPS, although to varying degrees [11]. This evidence concerns the gene DUOXA2 and pancreatic neoplasm.